SCHEMBL31730324

CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CS)[C@@H](C)O)C(=O)O

nearest known ligand 0.67

Predicted protein targets (top 9)

	gene	UniProt	supporting neighbours	confidence
▸	CXCR4	P61073	1/20	0.60

▸	NPY2R	P49146	7/20	0.59

▸	NPY4R	P50391	7/20	0.59

▸	NPY5R	Q15761	7/20	0.59

▸	NPY1R	P25929	5/20	0.59

▸	EPHA2	P29317	2/20	0.58

▸	TFPI	P10646	4/20	0.58

▸	RAMP3	O60896	5/20	0.58

▸	CALCR	P30988	5/20	0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30262202	0.95	CXCR4 (0.59)	CXCR4NPY2RNPY4RNPY5RNPY1R
SCHEMBL29392765	0.91	EPHA2 (0.57)	CXCR4NPY2RNPY4RNPY5RNPY1R
SCHEMBL30607391	0.90	CXCR4 (0.64)	CXCR4NPY2RNPY4RNPY5RNPY1R
SCHEMBL29695550	0.90	CXCR4 (0.60)	CXCR4NPY2RNPY4RNPY5RNPY1R
SCHEMBL31281288	0.90	MAPK8 (0.60)	CXCR4NPY2RNPY4RNPY5RNPY1R
SCHEMBL29390108	0.90	EPHA2 (0.62)	CXCR4NPY2RNPY4RNPY5RNPY1R
SCHEMBL29389698	0.90	EPHA2 (0.56)	CXCR4NPY2RNPY4RNPY5RNPY1R
SCHEMBL29531542	0.89	NPY2R (0.63)	CXCR4NPY2RNPY4RNPY5RNPY1R
SCHEMBL30495779	0.89	NPY2R (0.65)	CXCR4NPY2RNPY4RNPY5RNPY1R
SCHEMBL31182566	0.89	TFPI (0.68)	CXCR4NPY2RNPY4RNPY5RNPY1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20250354138-A1	PRIME EDITING OF SINGLE BASE MUTATIONS IN ALPHA-1 ANTITRYPSIN DEFICIENCY	BEAM THERAPEUTICS INC (US)	2025-11-20	—	—	US	disclosed